Bank of New York Mellon
ASTX

Bank of New York Mellon’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Bank of New York Mellon’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-476,927
Closed -$4.05M – 4323
2013
Q3 		$4.05M Sell
476,927
-13,295
-3% -$84.1K ﹤0.01% 2361
2013
Q2 		$2.02M Buy
+490,222
New +$2.64M ﹤0.01% 2784

Bank of New York Mellon's ASTX Position: Q4 2013 in Review

Bank of New York Mellon sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 476,927 shares — an estimated $4.05M sold.

Bank of New York Mellon first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $4.05M in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Bank of New York Mellon reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Bank of New York Mellon sold 476,927 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $4.05M.
  • Bank of New York Mellon first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • Bank of New York Mellon's ASTEX PHARMACEUTICALS, INC COM position peaked at $4.05M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Bank of New York Mellon's 13F filing for Q4 2013, filed 12 Feb 2014.